These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 503893)

  • 41. [Present state of immunotherapy of tumours (author's transl)].
    Rieche K
    Arch Geschwulstforsch; 1974; 44(2):167-81. PubMed ID: 4375452
    [No Abstract]   [Full Text] [Related]  

  • 42. [Immunology and immunotherapy of malignant neoplasms and blood diseases].
    Papaleo G; Zito GA; Giordano G
    Recenti Prog Med; 1978 Mar; 64(3):310-53. PubMed ID: 351752
    [No Abstract]   [Full Text] [Related]  

  • 43. [The role of interleukin-2--based immunotherapy in hematological malignancies].
    Ackerstein A; Toren A; Slavin S; Nagler A
    Harefuah; 1996 May; 130(9):613-7. PubMed ID: 8794642
    [No Abstract]   [Full Text] [Related]  

  • 44. The Cancer Defense.
    Weintraub K
    Sci Am; 2016 Apr; 314(4):42-51. PubMed ID: 27082190
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunotherapy from malignant disease.
    Goodnight JE; Morton DL
    Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
    [No Abstract]   [Full Text] [Related]  

  • 46. Prospects for immunotherapy of MHC class I-deficient tumours.
    Bubeník J
    Folia Biol (Praha); 2003; 49(3):95-9. PubMed ID: 12859017
    [No Abstract]   [Full Text] [Related]  

  • 47. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
    Mathé G
    Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
    [No Abstract]   [Full Text] [Related]  

  • 48. Dendritic cell vaccine against leukemia: advances and perspectives.
    Tesfatsion DA
    Immunotherapy; 2014; 6(4):485-96. PubMed ID: 24815786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experimental and selected clinical aspects of active immunotherapy in leukemia].
    Luczyński W; Krawczuk-Rybak M; Stasiak-Barmuta A
    Postepy Hig Med Dosw (Online); 2006; 60():379-86. PubMed ID: 16885908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunotherapeutic aspects of stem cell transplantation.
    Madrigal JA; Travers PJ; Dodi IA
    Hematology; 2005; 10 Suppl 1():289-92. PubMed ID: 16188689
    [No Abstract]   [Full Text] [Related]  

  • 51. Adoptive immunotherapy.
    Sharp J
    Lancet; 1989 May; 1(8645):1025. PubMed ID: 2565504
    [No Abstract]   [Full Text] [Related]  

  • 52. [Present status in studying immunotherapy for acute leukemia and its perspective--Editorial].
    Wang ZY; Chen QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):169-73. PubMed ID: 15854271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Principles and aims of the treatment of leukaemia (author's transl)].
    Krepler P
    Wien Klin Wochenschr; 1978 Dec; 90(23):817-25. PubMed ID: 369148
    [No Abstract]   [Full Text] [Related]  

  • 54. [Immunotherapy of cancer. Basic principles, possibilities, dangers, problems and conditions].
    Meiss L; Romieu C; Serrou B
    Dtsch Med Wochenschr; 1973 Jun; 98(23):1179-85. PubMed ID: 4576228
    [No Abstract]   [Full Text] [Related]  

  • 55. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.
    Rosenberg SA; Lotze MT
    Annu Rev Immunol; 1986; 4():681-709. PubMed ID: 3518753
    [No Abstract]   [Full Text] [Related]  

  • 56. Cytokine treatment in cancer immunotherapy.
    Ardolino M; Hsu J; Raulet DH
    Oncotarget; 2015 Aug; 6(23):19346-7. PubMed ID: 26305981
    [No Abstract]   [Full Text] [Related]  

  • 57. [Immunotherapy in neoplasms. Part II--methods (author's transl)].
    Szmigiel Z; Skotnicki AB
    Przegl Lek; 1975; 32(9):706-11. PubMed ID: 242038
    [No Abstract]   [Full Text] [Related]  

  • 58. [Use of monoclonal antibodies in the immunotherapy of neoplasms].
    Robak T
    Przegl Lek; 1989; 46(4):420-6. PubMed ID: 2672121
    [No Abstract]   [Full Text] [Related]  

  • 59. Tumor therapy with monoclonal antibodies.
    Levy R; Miller RA
    Fed Proc; 1983 Jun; 42(9):2650-6. PubMed ID: 6343125
    [No Abstract]   [Full Text] [Related]  

  • 60. Possible application of natural killer cells and interleukin-2 in therapy of human leukemia.
    Lotzová E
    Prog Clin Biol Res; 1987; 244():259-66. PubMed ID: 3498951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.